October 24, 2016
Off
Biophytis outsources AMD drug production to Patheon, USA
By Dino MustafićBiophytis has entered into an agreement with US firm Patheon for the industrial …
Pharmaceuticals, Biotechnology and Life Sciences
BIOPHYTIS, a biotechnology company specialized in the development of drug candidates to treat aging diseases, has announced the implementation of a proprietary e-Health platform, SARA-data, to process patient data from its SARA clinical studies.
Biophytis has appointed Pierre J. Dilda, PhD, as Director of
Research.